Low Molecular Weight Heparins Can Lead To Hyperkalaemia
— · The Internet Journal of Geriatrics and Gerontology · 2005
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
The Internet Journal of Geriatrics and Gerontology · OpenAlex · article · 2005
Abstract
Low molecular weight heparins (LMWH) have an important role in the management of many clinical conditions, either prophylactically or therapeutically.1,2,3 They are known to cause side-effects such as haemorrhage, thrombocytopenia, hypersensitivity reactions, skin necrosis and osteoporosis.1 Hyperkalaemia is a recognised side-effect of heparin and LMWH use, but this may be easily overlooked in a clinician's day-to-day practise.1,2,3,4,5 A case of Clexane (enoxaparin) induced hyperkalaemia in an elderly patient on a surgical ward is described.
Open the resolved locator · 10.5580/10be
Metadata licence: OpenAlex metadata (CC0)